Join CRF on Rare Disease Day February 29, 2024 and Celebrate 21 Years of Research Progress!
What is a rare disease? Our community might be small in numbers, but our determination to cure cystinosis is unstoppable! We have more work to
Research Progress Report by Dr. Benjamin S. Freedman, Associate Professor, University of Washington
CRF issued the first grant award to Benjamin ‘Beno’ Freedman, PhD, in 2021 to support his important research on developing a therapeutic strategy for nephropathic
Join Us on Rare Disease Day February 28, 2024 and Celebrate More Than 20 Years of CRF Research Progress
What is a rare disease? Our community might be small in numbers, but our determination to cure cystinosis is unstoppable! We have more work to
Cystinosis Community Statement October 2023 – Novartis Acquires AVROBIO
Dear Cystinosis Community, In May 2023, Novartis acquired the investigational autologous hematopoietic stem cell (HSC) gene therapy program for the treatment of cystinosis from AVROBIO.
Research Progress Report by Drs. Francesco Emma and Anna Taranta, Bambino Gesù Children’s Hospital
Researchers Francesco Emma, MD, Head Nephrology Unit, and Anna Taranta, PhD, Senior Research Associate, received grant funding in 2022 for their research on the “Impact
Research Grant Progress Report by Liang Feng, PhD, Associate Professor, Stanford University in California
Researcher Liang Feng, PhD, Associate Professor of Molecular and Cellular Physiology at Stanford University, received a grant award in 2022 for his research “Investigating the